Anti-inflammatory and anti-fibrotic effects of berberine-loaded liquid crystalline nanoparticles

• Amlan Chakraborty,
• Keshav Raj Paudel,
• Chao Wang,
• Gabriele De Rubis,
• Dinesh Kumar Chellappan,
• Philip Michael Hansbro,
• Chrishan S. Samuel,
• Kamal Dua

Affiliations

Amlan Chakraborty

ORCiD

Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester M13 9PL, U.K. E-mail [email protected]

Keshav Raj Paudel

ORCiD

Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, New South Wales 2050 & 2007, Australia

Chao Wang

ORCiD

Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, VIC 3800, Australia

Gabriele De Rubis

ORCiD

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia

Dinesh Kumar Chellappan

ORCiD

Department of Life Sciences, School of Pharmacy, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, 57000, Malaysia

Philip Michael Hansbro

ORCiD

Centre for Inflammation, Centenary Institute & University of Technology Sydney, School of Life Sciences, Faculty of Science, Sydney, New South Wales 2050 & 2007, Australia

Chrishan S. Samuel

ORCiD

Cardiovascular Disease Program, Biomedicine Discovery Institute and Department of Pharmacology, Monash University, Clayton, VIC 3800, Australia

Kamal Dua

ORCiD

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia. E-mail: [email protected]